Maxim Group started coverage on shares of Draganfly (NASDAQ:DPRO – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The firm issued a buy rating and a $7.00 price target on the stock. Separately, HC Wainwright upped their price target on shares of Draganfly from $0.50 to $7.00 and gave the company a […]

Pivotal Research assumed coverage on shares of Meta Platforms (NASDAQ:META – Free Report) in a research report report published on Tuesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $780.00 price target on the social networking company’s stock. A number of other analysts also recently weighed in on META. Cantor Fitzgerald […]

Scotiabank assumed coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Monday, Marketbeat.com reports. The brokerage issued a sector outperform rating and a $20.00 price target on the stock. Several other research analysts have also recently issued reports on the stock. Craig Hallum began coverage on shares of […]

Equities research analysts at Stifel Nicolaus initiated coverage on shares of Amdocs (NASDAQ:DOX – Get Free Report) in a report issued on Wednesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $100.00 price target on the technology company’s stock. Stifel Nicolaus’ target price would indicate a potential upside of 13.43% from the […]

Investment analysts at Craig Hallum assumed coverage on shares of Thryv (NASDAQ:THRY – Get Free Report) in a research report issued on Wednesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $25.00 price target on the stock. Craig Hallum’s price target points to a potential upside of 50.97% from the company’s previous […]

Oppenheimer began coverage on shares of Euronet Worldwide (NASDAQ:EEFT – Get Free Report) in a report released on Tuesday, MarketBeat reports. The firm set an “outperform” rating and a $121.00 price target on the business services provider’s stock. Oppenheimer’s price objective would indicate a potential upside of 23.98% from the company’s previous close. A number […]

Equities researchers at Wolfe Research assumed coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $84.00 price target on the biopharmaceutical company’s stock. Wolfe Research’s target price indicates a potential upside of […]